29 related articles for article (PubMed ID: 1997177)
1. Can localised (19)F magnetic resonance spectroscopy pharmacokinetics of 5FU in colorectal metastases predict clinical response?
McIntyre DJ; Howe FA; Ladroue C; Lofts F; Stubbs M; Griffiths JR
Cancer Chemother Pharmacol; 2011 Jul; 68(1):29-36. PubMed ID: 20821329
[TBL] [Abstract][Full Text] [Related]
2. Kinetic analysis of hyaluronidase activity using a bioactive MRI contrast agent.
Shiftan L; Neeman M
Contrast Media Mol Imaging; 2006; 1(3):106-12. PubMed ID: 17193686
[TBL] [Abstract][Full Text] [Related]
3. Carbogen breathing differentially enhances blood plasma volume and 5-fluorouracil uptake in two murine colon tumor models with a distinct vascular structure.
van Laarhoven HW; Gambarota G; Lok J; Lammens M; Kamm YL; Wagener T; Punt CJ; van der Kogel AJ; Heerschap A
Neoplasia; 2006 Jun; 8(6):477-87. PubMed ID: 16820094
[TBL] [Abstract][Full Text] [Related]
4. 5-Fluorouracil metabolism and cytotoxicity after pre-treatment with methotrexate or thymidine in human hypopharynx and colon carcinoma xenografts: a 19F-nuclear magnetic resonance spectroscopy study in vivo.
Tausch-Treml R; Baumgart F; Ziessow D; Köpf-Maier P
Cancer Chemother Pharmacol; 1996; 37(3):259-65. PubMed ID: 8529287
[TBL] [Abstract][Full Text] [Related]
5. Enhanced 5-fluorouracil cytotoxicity and elevated 5-fluoronucleotides in the rat Walker carcinosarcoma following methotrexate pre-treatment: a 19F-MRS study in vivo.
McSheehy PM; Prior MJ; Griffiths JR
Br J Cancer; 1992 Mar; 65(3):369-75. PubMed ID: 1558790
[TBL] [Abstract][Full Text] [Related]
6. Preclinical development and current status of the fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR 4554, CRC 94/17): a non-invasive diagnostic probe for the measurement of tumor hypoxia by magnetic resonance spectroscopy and imaging, and by positron emission tomography.
Aboagye EO; Kelson AB; Tracy M; Workman P
Anticancer Drug Des; 1998 Sep; 13(6):703-30. PubMed ID: 9755726
[TBL] [Abstract][Full Text] [Related]
7. Thymidine-modulated 5-fluorouracil metabolism in liver and RIF-1 tumors studied by 19F magnetic resonance spectroscopy.
Sijens PE; Ng TC
Magn Reson Imaging; 1992; 10(3):385-92. PubMed ID: 1406088
[TBL] [Abstract][Full Text] [Related]
8. pH dependence of 5-fluorouracil uptake observed by in vivo 31P and 19F nuclear magnetic resonance spectroscopy.
Guerquin-Kern JL; Leteurtre F; Croisy A; Lhoste JM
Cancer Res; 1991 Oct; 51(20):5770-3. PubMed ID: 1913695
[TBL] [Abstract][Full Text] [Related]
9. Carbogen breathing increases 5-fluorouracil uptake and cytotoxicity in hypoxic murine RIF-1 tumors: a magnetic resonance study in vivo.
McSheehy PM; Robinson SP; Ojugo AS; Aboagye EO; Cannell MB; Leach MO; Judson IR; Griffiths JR
Cancer Res; 1998 Mar; 58(6):1185-94. PubMed ID: 9515804
[TBL] [Abstract][Full Text] [Related]
10. Multinuclear MR investigation of the metabolic response of the murine RIF-1 tumor to 5-fluorouracil chemotherapy.
Sijens PE; Baldwin NJ; Ng TC
Magn Reson Med; 1991 Jun; 19(2):373-85. PubMed ID: 1908937
[TBL] [Abstract][Full Text] [Related]
11. Metabolites of 5-fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment.
Hull WE; Port RE; Herrmann R; Britsch B; Kunz W
Cancer Res; 1988 Mar; 48(6):1680-8. PubMed ID: 3125967
[TBL] [Abstract][Full Text] [Related]
12. 19F magnetic resonance spectroscopy studies of the metabolism of 5-fluorouracil in murine RIF-1 tumors and liver.
Sijens PE; Huang YM; Baldwin NJ; Ng TC
Cancer Res; 1991 Mar; 51(5):1384-90. PubMed ID: 1997177
[TBL] [Abstract][Full Text] [Related]
13. Fluorine nuclear magnetic resonance spectroscopy of human biofluids in the field of metabolic studies of anticancer and antifungal fluoropyrimidine drugs.
Malet-Martino M; Gilard V; Desmoulin F; Martino R
Clin Chim Acta; 2006 Apr; 366(1-2):61-73. PubMed ID: 16337167
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
